Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) shares, rose in value on Wednesday, April 16, with the stock price down by -2.36% to the previous day’s close as strong demand from buyers drove the stock to $0.50.
Actively observing the price movement in the last trading, the stock closed the session at $0.51, falling within a range of $0.48 and $0.5445. The value of beta (5-year monthly) was 1.026. Referring to stock’s 52-week performance, its high was $2.45, and the low was $0.28. On the whole, LXRX has fluctuated by 39.08% over the past month.
With the market capitalization of Lexicon Pharmaceuticals Inc currently standing at about $180.75 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-05.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.26M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that LXRX’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of LXRX currently trading nearly 10.79% and -3.47% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.25, while the 7-day volatility ratio is showing 11.33% which for the 30-day chart, stands at 17.30%. Furthermore, Lexicon Pharmaceuticals Inc (LXRX)’s beta value is 1.11, and its average true range (ATR) is 0.08.
A comparison of Lexicon Pharmaceuticals Inc (LXRX) with its peers suggests the former has fared considerably weaker in the market. LXRX showed an intraday change of -2.36% in last session, and over the past year, it shrunk by -74.62%%.
Data on historical trading for Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) indicates that the trading volumes over the past 10 days have averaged 9.17 and over the past 3 months, they’ve averaged 15.17 million. According to company’s latest data on outstanding shares, there are 361.49 million shares outstanding.
Nearly 50.33% of Lexicon Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 34.85% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 43.88 million shares as on 2025-03-31, resulting in a short ratio of 1.41. According to the data, the short interest in Lexicon Pharmaceuticals Inc (LXRX) stood at 2692.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 47.46 million. The stock has fallen by -32.30% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the LXRX stock heading into the next quarter.
